期刊文献+

IL-18在多发性肌炎和皮肌炎患者血清中的变化和意义 被引量:2

原文传递
导出
摘要 目的检测多发性肌炎(PM)和皮肌炎(DM)患者血清中IL-18的水平,结合临床表现及各项实验室指标,探讨IL-18与疾病活动的相关性。方法采用酶联免疫吸附法(ELISA)检测60例PM/DM患者和30例正常对照者外周血中IL-18的水平。结果PM/DM患者IL-18水平[(212.57±174.62)ng/L]较正常对照组[(23.25±12.30)ng/L]升高,差异有显著性(P〈0.05);活动期PM/DM患者IL—18水平[(273.57±180.72)ng/L]明显高于非活动期[(78.60±39.04)ng/L](P〈0.05);PM患者IL-18[(185.09±150.17)ng/L]与DM患者IL-18[(229.65±188.17)ng/L]比较,差异无统计学意义(P〉0.05);PM/DM患者IL-18的水平与血清肌酸激酶、血沉、C反应蛋白有相关性。结论在PM/DM患者外周血IL-18水平明显升高,IL-18与PM/DM疾病活动性及实验室某些指标相关,可作为观察疾病活动性及监测治疗效果的指标。
出处 《临床内科杂志》 CAS 2010年第9期626-627,共2页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献5

  • 1Salomonsson S,Lundberg IE.Cytokinnes In idiopathic inflammatory myopathies.Autoimmunity,2006,39:177-190.
  • 2M Aleksza,A Szegedi,P sAntal-Szalmas,et al.Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.Ann Rheum dis,2005,64:1485-1489.
  • 3Lundberg IE.The role of cytokine,chemokines,and adhesion in the pathogenesis of idiopathic inflammatory myopathies.Curr Rheumatol Rep,2000,2:216-224.
  • 4M Tucci,C Quatraro,F Dammacco.Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.Clinical and Experimental immunology,2006,146:21-31.
  • 5Tucci M,Quatraro C,Dammacco F,et al.Increased IL-18 production by dendritic cells in active inflammatory myopathies.Ann N Y Acad Sci,2007,1107:184-192.

同被引文献23

  • 1Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol, 2008, 29: 313-321.
  • 2Verbruggen LA, Rebmann V, Demanet C, et al. Soluble HLA-G in rheumatoid arthritis. Hum Immunol, 2006, 67: 561-567.
  • 3Rizzo R, Hviid TV, Govoni M, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus:HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens, 2008, 71: 520-529.
  • 4Wiendl H, Behrens L, Maier S, et al. Muscle fibers in inflam- matory myopathies and cultured myoblasts express the nonclassi- cal major histocompatibility antigen HLA-G. Ann Neurol, 2000, 48 : 679-684.
  • 5Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med, 1975, 292: 344-347.
  • 6Veit TD, Chies JA. Tolerance versus immune response-micro- RNAs as important dements in the regulation of the HLA-G gene expression. Transpl Immunol, 2009, 20:229-231.
  • 7Carosella ED, Moreau P, Lemaoult J, et al. HLA-G: from biology to clinical benefits. Trends Immunol, 2008, 29: 125- 132.
  • 8Hughes AL, Nei M. Evolution of the major histoeompatibility complex: independent origin of nonclassical class I genes in different groups of mammals. Mol Biol Evol, 1989, 6: 559-579.
  • 9Baricordi OR, Stignani M, Melchiorri L, et al. HLA-G and in- flammatory diseases. Inflamm Allergy Drug Targets, 2008, 7: 67-74.
  • 10Waschbisch A, Sandbrink R, Hartung HP, et al. Evaluation of soluble HLA-G as a biomarker for multiple sclerosis. Neurology, 2011, 77: 596-598.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部